Skip to main content

CORRECTION article

Front. Oncol., 12 November 2018
Sec. Molecular and Cellular Oncology
Volume 8 - 2018 | https://doi.org/10.3389/fonc.2018.00441

Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias

This article is a correction to:

  1. Metabolic Reprogramming During Multidrug Resistance in Leukemias

    1. Read original article
\r\nRaphael Silveira VidalRaphael Silveira Vidal1Julia Quarti,Julia Quarti1,2Mariana Figueiredo RodriguesMariana Figueiredo Rodrigues1Franklin D. RumjanekFranklin D. Rumjanek1Vivian M. Rumjanek*Vivian M. Rumjanek1*
  • 1Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
  • 2Instituto de Nutrição Josué de Castro, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

A Corrigendum on
Metabolic Reprogramming During Multidrug Resistance in Leukemias

by Vidal, R. S., Quarti, J., Rodrigues, M. F., Rumjanek, F. D., and Rumjanek, V. M. (2018). Front. Oncol. 8:90. doi: 10.3389/fonc.2018.00090

Mariana Figueiredo Rodrigues was not included as an author in the published article. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: multidrug resistance, glycolysis, glyceraldehyde-3-phosphate dehydrogenase, leukemia, reactive oxygen species

Citation: Vidal RS, Quarti J, Rodrigues MF, Rumjanek FD and Rumjanek VM (2018) Corrigendum: Metabolic Reprogramming During Multidrug Resistance in Leukemias. Front. Oncol. 8:441. doi: 10.3389/fonc.2018.00441

Received: 20 September 2018; Accepted: 21 September 2018;
Published: 12 November 2018.

Approved by:

Frontiers in Oncology Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2018 Vidal, Quarti, Rodrigues, Rumjanek and Rumjanek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Vivian M. Rumjanek, vivian@bioqmed.ufrj.br

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.